## **Core Concept**
The phases of clinical trials are crucial in the development and testing of new drugs or treatments. Ethical clearance is a vital component in ensuring the safety and rights of participants in these trials. The phases of clinical trials include Phase 1 (first-in-human trials), Phase 2 (proof-of-concept and dose-finding), Phase 3 (confirmatory trials), and Phase 4 (post-marketing surveillance).

## **Why the Correct Answer is Right**
Phase 4 clinical trials, also known as post-marketing surveillance trials, are conducted after a drug or treatment has received approval for consumer sale. The primary goal of Phase 4 trials is to monitor the drug's performance in a larger, more diverse population and to collect data on any side effects associated with long-term use. Since these trials involve drugs that have already been approved and are on the market, and often the research is observational or involves standard treatments, the requirement for ethical clearance may differ compared to the earlier phases. However, it's essential to note that some form of oversight or review may still occur to ensure participant safety.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Phase 1 trials are the first stage of testing in human subjects and involve a small group of healthy volunteers or patients. Ethical clearance is strictly required for Phase 1 trials to ensure that the risks to participants are minimized and that they provide informed consent.
- **Option B:** Phase 2 trials involve more participants, often patients with the condition the drug aims to treat. Ethical clearance is necessary here as well, to protect the rights and welfare of these patients.
- **Option C:** Phase 3 trials are large-scale trials that seek to confirm the efficacy of the drug, monitor side effects, compare it to commonly used treatments, and collect information that will allow the experimental drug to be used safely. Ethical clearance is required for these trials due to the large number of participants and the potential risks involved.

## **Clinical Pearl / High-Yield Fact**
A critical point to remember is that while ethical clearance might not be required in the same rigorous manner for Phase 4 trials as for earlier phases, there's often still some form of review or monitoring to ensure participant safety. This could involve Institutional Review Board (IRB) or Ethics Committee (EC) review, especially if the Phase 4 trial involves any deviation from standard treatment protocols or if it aims to gather new data on efficacy or side effects.

## **Correct Answer:** D. Phase 4.